Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...

Nobody knew anything." Worse still, she added, they "really didn't want to hear about it." Many clinicians remain unaware of ...